ロード中...
Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
BACKGROUND: Drug-induced colitis is a known complication of therapies that alter the immune balance, damage the intestinal barrier or disturb intestinal microbiota. Immune checkpoint inhibitors (ICI) directed against cancer cells may result in activated T lymphocyte-induced immune-related adverse ev...
保存先:
| 出版年: | Therap Adv Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831976/ https://ncbi.nlm.nih.gov/pubmed/31723355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819884196 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|